View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Stitch Fix Announces Date for Third Quarter 2024 Financial Results and...

Stitch Fix Announces Date for Third Quarter 2024 Financial Results and Conference Call SAN FRANCISCO, May 21, 2024 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its third quarter fiscal year 2024 ended April 27, 2024 after market close on Tuesday, June 4, 2024. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of th...

 PRESS RELEASE

New Angi Report Finds Nearly 90% of Skilled Tradespeople Satisfied in ...

New Angi Report Finds Nearly 90% of Skilled Tradespeople Satisfied in Their Careers DENVER, May 21, 2024 (GLOBE NEWSWIRE) -- , a leading and comprehensive solution for improving and maintaining homes, today released its Skilled Trades in America Report. The report highlights a trend that stands in stark contrast to anxieties in many sectors: exceptionally high job satisfaction in the skilled trades industry. While concerns about AI replacing jobs are prevalent across industries, skilled trades professionals report feeling secure. According to Angi’s data, a staggering 90% of tradespeople...

 PRESS RELEASE

Stitch Fix Announces New Employee Inducement Grant

Stitch Fix Announces New Employee Inducement Grant SAN FRANCISCO, May 17, 2024 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that effective May 15, 2024, the compensation committee of the company’s board of directors granted restricted stock units (RSUs) to one new employee to acquire 118,722 shares of the company’s Class A common stock. One fourth of these restricted stock units will vest on June 12, 2024, and the remainder will vest in 3 equal quarterly installments of 1/4th over the next three subsequent quarterly RSU v...

 PRESS RELEASE

Collegium Announces $35 Million Accelerated Share Repurchase Program

Collegium Announces $35 Million Accelerated Share Repurchase Program STOUGHTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has entered into an Accelerated Share Repurchase ("ASR") agreement with Jefferies LLC to repurchase $35 million of the Company’s common stock. Collegium will execute the ASR as part of the $150 million share repurchase program authorized by its Board of Directors in January 2024. Upon completio...

 PRESS RELEASE

Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Dr...

Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif., May 10, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the Ekso Indego Personal will be featured on ‘Health Uncensored’ hosted by Dr. Drew Pinsky. The episode is scheduled to air on the Fox Business News channel on Sunday, May 12 at 5:30 p.m. ET / 2:30 p.m. PT. Scott Dav...

 PRESS RELEASE

Collegium Reports First Quarter 2024 Financial Results

Collegium Reports First Quarter 2024 Financial Results – Generated Q1’24 Net Revenue of $144.9 Million – – Delivered Q1’24 Record Belbuca® Revenue of $50.7 Million; Total Prescriptions Up 4.2% Year-over-Year – – Achieved Q1’24 GAAP Net Income of $27.7 Million vs. Q1’23 GAAP Net Loss of $(17.4) Million – – Delivered Q1’24 Adjusted EBITDA of $92.4 Million, Up 5% Year-over-Year – – Board of Directors Authorized $35.0 Million Accelerated Share Repurchase Program – – Reaffirmed Full-Year 2024 Guidance – – Conference Call Scheduled for Today ...

 PRESS RELEASE

Collegium Announces CEO Transition

Collegium Announces CEO Transition – Joe Ciaffoni to Step Down as President and Chief Executive Officer – – Board Chairman Michael Heffernan to Serve as Interim President and Chief Executive Officer – – Board of Directors has Initiated the Search for a Successor – STOUGHTON, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that effective May 24, 2024, Joe Ciaffoni will step down as President and Chief Executive Officer...

 PRESS RELEASE

Angi Inc. Earnings Release Available on Company’s Website

Angi Inc. Earnings Release Available on Company’s Website DENVER, May 07, 2024 (GLOBE NEWSWIRE) -- Angi Inc. (NASDAQ: ANGI) posted its first quarter financial results on the investor relations section of its website at . As announced previously, Angi Inc. and IAC will host a conference call to discuss both companies’ respective first quarter results and to answer questions. The call will be held on Wednesday, May 8, 2024, at 8:30 a.m. ET. Joey Levin, CEO of IAC and Chairman of Angi Inc., Jeffrey Kip, CEO of Angi Inc. and Christopher Halpin, Executive Vice President, CFO and COO of IAC, wi...

 PRESS RELEASE

OPKO Health Reports First Quarter 2024 Business Highlights and Financi...

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights include the following: Entered into an agreement with Labcorp to sell select assets of BioReference Health. The transaction includes the sale of BioReference Health’s laboratory testing businesses focused on clinical diagnostics and women’s health, excludi...

 PRESS RELEASE

This National Signing Day, Angi Aims to Boost Hiring in the Trades

This National Signing Day, Angi Aims to Boost Hiring in the Trades Angi expands partnership with trades job platform BlueRecruit and launches new scholarship program to raise awareness of the benefits of the trades and help close the labor gap DENVER, May 06, 2024 (GLOBE NEWSWIRE) -- , a leading and comprehensive solution for improving and maintaining homes, today launched several new initiatives in advance of May 7th’s National Signing Day–a day to acknowledge and celebrate students who pursue an undergraduate or graduate trade school training program. Launched today, the Angi Trade Up...

 PRESS RELEASE

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2...

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register f...

 PRESS RELEASE

Dorchester Minerals, L.P. Announces First Quarter Results

Dorchester Minerals, L.P. Announces First Quarter Results DALLAS, May 02, 2024 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the quarter ended March 31, 2024 of $18,167,000, or $0.44 per common unit. A comparison of the Partnership’s consolidated results for the quarter ended March 31, 2024 and 2023 are set forth below:   Three Months Ended  March 31,  2024 2023Operating Revenues $30,979,000  $40,167,000Net Income $18,167,000  $28,070,000Net Income Per Common Unit $0.44  $0.71 The Partnership previously ...

 PRESS RELEASE

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results...

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared to the same period in 2023.Declares a regular quarterly cash dividend of $0.15 per common share for the second quarter of 2024, payable May 30, 2024. WINTER SPRINGS, Fla., May ...

 PRESS RELEASE

Compass Diversified Reports First Quarter 2024 Financial Results

Compass Diversified Reports First Quarter 2024 Financial Results WESTPORT, Conn., May 01, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today its consolidated operating results for the three months ended March 31, 2024. “We started 2024 on a strong note especially when you look at the performance of our Branded Consumer businesses, which only underscores the effectiveness of our well-defined, strategic pivot to own and manage companies at the forefront of innovation and disruptive growth,” said...

 PRESS RELEASE

Compass Diversified Announces Sale of Crosman Air Gun Business

Compass Diversified Announces Sale of Crosman Air Gun Business WESTPORT, Conn., April 30, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, is announcing the simultaneous entry into a definitive agreement (the “Agreement”) and completion of its sale of Crosman Corporation (“Crosman”), the air gun division of its Velocity Outdoor, Inc. subsidiary, to Daisy Manufacturing Company (“Daisy”). Crosman is a leading designer, manufacturer and marketer of air guns, accessories and related consumables sold under the C...

 PRESS RELEASE

Ekso Bionics Announces First Quarter 2024 Financial Results

Ekso Bionics Announces First Quarter 2024 Financial Results SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2024. Recent Highlights and Accomplishments Received final payment determination for Medicare reimbursement from the Centers for Medicare & Medicaid Services (“CMS”) for Ekso Indego PersonalReported revenues of $3.8 million for the first quarter of 2024...

 PRESS RELEASE

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceut...

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER STOUGHTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced it has entered into an authorized generic agreement with Hikma Pharmaceuticals USA Inc. (“Hikma”), pursuant to which Hikma will have the exclusive right to sell the authorized generic versions of Nucynta® and Nucynta® ER (“th...

 PRESS RELEASE

First Savings Financial Group, Inc. Reports Financial Results for The ...

First Savings Financial Group, Inc. Reports Financial Results for The Second Fiscal Quarter Ended March 31, 2024 JEFFERSONVILLE, Ind., April 25, 2024 (GLOBE NEWSWIRE) -- First Savings Financial Group, Inc. (NASDAQ: FSFG - news) (the "Company"), the holding company for First Savings Bank (the "Bank"), today reported net income of $4.9 million, or $0.72 per diluted share, for the quarter ended March 31, 2024 compared to net income of $3.7 million, or $0.54 per diluted share, for the quarter ended March 31, 2023. Excluding nonrecurring items, the Company reported net income of $3.6 million (...

 PRESS RELEASE

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conf...

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, . Once registered, a dial-i...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch